ACB
EHC icon

Aristotle Capital Boston’s Encompass Health EHC Stock Holding History

Aristotle Capital Boston’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.02M Sell
39,723
-9,529
-19% -$987K 0.27% 100
2026
Q1 		$4.8M Sell
49,252
-1,078
-2% -$111K 0.3% 99
2025
Q4 		$5.34M Sell
50,330
-4,342
-8% -$503K 0.29% 99
2025
Q3 		$6.94M Sell
54,672
-3,748
-6% -$446K 0.36% 94
2025
Q2 		$7.16M Sell
58,420
-11,057
-16% -$1.26M 0.36% 89
2025
Q1 		$7.04M Sell
69,477
-27,292
-28% -$2.66M 0.35% 88
2024
Q4 		$8.94M Sell
96,769
-8,218
-8% -$807K 0.33% 91
2024
Q3 		$10.1M Sell
104,987
-28,042
-21% -$2.52M 0.34% 90
2024
Q2 		$11.4M Sell
133,029
-34,136
-20% -$2.86M 0.38% 87
2024
Q1 		$13.8M Sell
167,165
-12,632
-7% -$925K 0.42% 87
2023
Q4 		$12M Sell
179,797
-22,729
-11% -$1.47M 0.37% 99
2023
Q3 		$13.6M Sell
202,526
-3,823
-2% -$263K 0.44% 87
2023
Q2 		$14M Buy
206,349
+9,010
+5% +$565K 0.42% 89
2023
Q1 		$10.7M Buy
197,339
+12,228
+7% +$712K 0.33% 105
2022
Q4 		$11.1M Sell
185,111
-7,013
-4% -$381K 0.35% 103
2022
Q3 		$8.69M Sell
192,124
-93,182
-33% -$4.66M 0.29% 114
2022
Q2 		$12.7M Buy
285,306
+25,553
+10% +$1.31M 0.38% 109
2022
Q1 		$14.7M Buy
259,753
+174
+0.1% +$9.09K 0.37% 109
2021
Q4 		$13.5M Buy
259,579
+30,170
+13% +$1.56M 0.32% 115
2021
Q3 		$13.7M Buy
229,409
+33,747
+17% +$2.12M 0.32% 112
2021
Q2 		$12.1M Sell
195,662
-4,586
-2% -$306K 0.28% 118
2021
Q1 		$13M Buy
200,248
+19,984
+11% +$1.3M 0.29% 115
2020
Q4 		$11.9M Buy
180,264
+25,163
+16% +$1.48M 0.28% 112
2020
Q3 		$8.02M Buy
155,101
+13,090
+9% +$672K 0.23% 116
2020
Q2 		$7M Buy
+142,011
New +$7.66M 0.21% 118

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aristotle Capital Boston's EHC Position: Q2 2026 in Review

Aristotle Capital Boston reduced its Encompass Health (EHC) stake by 19% in Q2 2026, selling an estimated $987K and leaving 39,723 shares worth $4.02M. The position accounts for 0.27% of the portfolio, ranked #100.

Aristotle Capital Boston first reported a position in EHC in Q2 2020 and has held it in 25 quarters since. The position peaked at $14.7M in Q1 2022. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Aristotle Capital Boston held 39,723 shares of Encompass Health worth $4.02M as of Q2 2026.
  • Aristotle Capital Boston sold 9,529 Encompass Health shares in Q2 2026, an estimated $987K.
  • Encompass Health made up 0.27% of Aristotle Capital Boston's portfolio in Q2 2026, its #100 holding.
  • Aristotle Capital Boston first reported a position in Encompass Health in Q2 2020 and has held it in 25 quarters since.
  • Aristotle Capital Boston's Encompass Health position peaked at $14.7M in Q1 2022.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Aristotle Capital Boston's 13F filing for Q2 2026, filed 14 Aug 2026.